MedPath

Virimmune

DRUG FACTS:

Approved
Approval ID

1d35a8ab-c06b-478d-8f7b-dbe9c7dbb3d4

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 27, 2025

Manufacturers
FDA

Deseret Biologicals, Inc.

DUNS: 940741853

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Aconitum Napellus, Allium Cepa, Allium Sativum, Arsenicum Album, Baptisia Tinctoria, Chelidonium Majus, Echinacea (Angustifolia), Gelsemium Sempervirens, Ginkgo Biloba, Hamamelis Virginiana, Influenzinum (2023-2024), Mercurius Vivus, Morbillinum, Natrum Muriaticum, Nux Vomica, Selenium Metallicum, Viscum Album

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43742-2145
Product Classification
G
Generic Name
Aconitum Napellus, Allium Cepa, Allium Sativum, Arsenicum Album, Baptisia Tinctoria, Chelidonium Majus, Echinacea (Angustifolia), Gelsemium Sempervirens, Ginkgo Biloba, Hamamelis Virginiana, Influenzinum (2023-2024), Mercurius Vivus, Morbillinum, Natrum Muriaticum, Nux Vomica, Selenium Metallicum, Viscum Album
Product Specifications
Route of AdministrationORAL
Effective DateMay 27, 2025
FDA Product Classification

INGREDIENTS (22)

ACONITUM NAPELLUS WHOLEActive
Quantity: 12 [hp_X] in 1 mL
Code: U0NQ8555JD
Classification: ACTIB
ONIONActive
Quantity: 12 [hp_X] in 1 mL
Code: 492225Q21H
Classification: ACTIB
GARLICActive
Quantity: 3 [hp_X] in 1 mL
Code: V1V998DC17
Classification: ACTIB
BAPTISIA TINCTORIA WHOLEActive
Quantity: 12 [hp_X] in 1 mL
Code: 5K1UO2888Y
Classification: ACTIB
CHELIDONIUM MAJUS WHOLEActive
Quantity: 12 [hp_X] in 1 mL
Code: 7E889U5RNN
Classification: ACTIB
ARSENIC TRIOXIDEActive
Quantity: 12 [hp_Q] in 1 mL
Code: S7V92P67HO
Classification: ACTIB
MEASLES VIRUSActive
Quantity: 12 [hp_X] in 1 mL
Code: HT3R7C012Q
Classification: ACTIB
GINKGOActive
Quantity: 3 [hp_X] in 1 mL
Code: 19FUJ2C58T
Classification: ACTIB
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARKActive
Quantity: 6 [hp_X] in 1 mL
Code: T7S323PKJS
Classification: ACTIB
INFLUENZA A VIRUS WHOLEActive
Quantity: 12 [hp_C] in 1 mL
Code: R9HH0NDE2E
Classification: ACTIB
INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLEActive
Quantity: 12 [hp_C] in 1 mL
Code: PMY5J4Z7LS
Classification: ACTIB
SODIUM CHLORIDEActive
Quantity: 12 [hp_X] in 1 mL
Code: 451W47IQ8X
Classification: ACTIB
SELENIUMActive
Quantity: 12 [hp_X] in 1 mL
Code: H6241UJ22B
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLEActive
Quantity: 12 [hp_C] in 1 mL
Code: PS2DCE2WVF
Classification: ACTIB
ECHINACEA ANGUSTIFOLIA WHOLEActive
Quantity: 3 [hp_X] in 1 mL
Code: VB06AV5US8
Classification: ACTIB
GELSEMIUM SEMPERVIRENS ROOTActive
Quantity: 12 [hp_X] in 1 mL
Code: 639KR60Q1Q
Classification: ACTIB
STRYCHNOS NUX-VOMICA SEEDActive
Quantity: 12 [hp_X] in 1 mL
Code: 269XH13919
Classification: ACTIB
MERCURYActive
Quantity: 12 [hp_X] in 1 mL
Code: FXS1BY2PGL
Classification: ACTIB
INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLEActive
Quantity: 12 [hp_C] in 1 mL
Code: CYK5P89K8X
Classification: ACTIB
VISCUM ALBUM FRUITING TOPActive
Quantity: 3 [hp_X] in 1 mL
Code: BK9092J5MP
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 4/3/2024

PACKAGE LABEL DISPLAY:

DesBio

Virimmune

Homeopathic

NDC 43742-2145-1

1 FL OZ (30 ml)

Virimmune

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 4/3/2024

USES:

• For the temporary relief of the symptoms including:

• congestion • cough • fever • fatigue • muscle pain

• joint pain • skin lesions • lack of appetite • stomach pain

These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 4/3/2024

QUESTIONS:

Dist. By: Deseret Biologicals, Inc.
469 W. Parkland Drive
Sandy, UT 84070

www.desbio.com

800-827-8204

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 4/3/2024

KEEP OUT OF REACH OF CHILDREN:

In case of overdose, contact a physician or Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 4/3/2024

DIRECTIONS:

1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 4/3/2024

INACTIVE INGREDIENTS:

Demineralized water, 25% ethanol

WARNINGS SECTION

LOINC: 34071-1Updated: 4/3/2024

WARNINGS:

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away.

Tamper Evident: Sealed for your protection. Do not use if seal is broken or missing.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 4/3/2024

ACTIVE INGREDIENT:

Aconitum Napellus 12X, Allium Cepa 12X, Allium Sativum 3X, Arsenicum Album 12X, Baptisia Tinctoria 12X, Chelidonium Majus 12X, Echinacea (Angustifolia) 3X, Gelsemium Sempervirens 12X, Ginkgo Biloba 3X, Hamamelis Virginiana 6X, 12X, 30X, Influenzinum 12C, 30C, Mercurius Vivus 12X, Morbillinum 12X, 30X, Natrum Muriaticum 12X, Nux Vomica 12X, Selenium Metallicum 12X, Viscum Album 3X.

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 4/3/2024

PURPOSE:

Aconitum Napellus - Congestion, Allium Cepa - Cough, Allium Sativum - Fever, Arsenicum Album- Fatigue, Baptisia Tinctoria – Muscle Pain, Chelidonium Majus – Joint Pain, Echinacea (Angustifolia – Skin Lesions, Gelsemium Sempervirens – Lack of Appetite, Ginkgo Biloba – Stomach Pain, Hamamelis Virginiana - Congestion, Influenzinum - Cough, Mercurius Vivus - Fever, Morbillinum - Fatigue, Natrum Muriaticum – Muscle Pain, Nux Vomica – Joint Pain, Selenium Metallicum – Skin Lesions, Viscum Album – Lack of Appetite

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Virimmune - FDA Drug Approval Details